Here’s what you should know:
1. The painkiller will be restricted to use in hospitals, surgery centers and emergency rooms. It won’t be available at retail pharmacies or for home use.
2. The opioid tablet is 1,000 times stronger than morphine and 10 times more potent than fentanyl.
3. Critics say the drug is likely to be abused, contributing to the opioid epidemic.
4. Dsuvia will be subject to “very tight restrictions,” and military use of the drug factored into the FDA’s approval, according to FDA Commissioner Scott Gottlieb, MD.
5. The medication comes in the form of a dissolvable tablet that shouldn’t be used for more than 72 hours.
More articles on supply chain:
Providers have power to help mistreated surgical equipment makers, study says: 6 insights
Takeda expected to win EU approval for Shire deal — Shareholder vote last hurdle
ASC supply chain tip of the day: Check your data
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.